Back to Search Start Over

Long-term outcomes after temporary placement of a self-expanding fully covered metal stent for benign biliary strictures secondary to chronic pancreatitis

Authors :
Sundeep Lakhtakia
Nageshwar Reddy
Werner Dolak
Thierry Ponchon
Marco J. Bruno
Michael J. Bourke
Horst Neuhaus
André Roy
Ferrán González-Huix Lladó
Paul P. Kortan
Joyce Peetermans
Matthew Rousseau
Guido Costamagna
Jacques Devière
Stephen J. Williams
Andreas Püspök
Barbara Tribl
Daniel Blero
Vincent Huberty
Myriam Delhaye
Arnaud Lemmers
Olivier Le Moine
Marianna Arvanitakis
Marylène Plasse
Gary May
Vincent Lepilliez
Brigitte Schumacher
Jean Pierre Charton
Christian Gerges
Torsten Beyna
D. Nageshwar Reddy
Andrea Tringali
Vincenzo Perri
Pietro Familiari
Massimiliano Mutignani
Jan W. Poley
Montserrat Figa Fransech
Thomas Bowman
David Carr-Locke
Gastroenterology & Hepatology
Source :
Gastrointestinal Endoscopy, 91, 2, pp. 361-369.e3, Gastrointestinal Endoscopy, 91, 361-369.e3, Gastrointestinal Endoscopy, 91(2), 361-+. Mosby Inc., Gastrointestinal endoscopy, 91 (2
Publication Year :
2020

Abstract

Background and Aims: Temporary single, fully covered self-expanding metal stent (FCSEMS) placement for benign biliary strictures (BBSs) associated with chronic pancreatitis (CP) may require fewer interventions than endotherapy with multiple plastic stents and may carry less morbidity than biliary diversion surgery. This study aimed to assess long-term outcomes in CP-associated BBSs after FCSEMS placement and removal. Methods: In this open-label, multinational, prospective study, subjects with CP and a BBS treated with FCSEMS placement with scheduled removal at 10 to 12 months were followed for 5 years after FCSEMS indwell. Kaplan-Meier analyses assessed BBS resolution and cumulative probability of freedom from recurrent stent placement to 5 years after FCSEMS indwell. Results: One hundred eighteen patients were eligible for FCSEMS removal. At a median of 58 months (interquartile range, 44-64) post-FCSEMS indwell, the probability of remaining stent-free was 61.6% (95% confidence interval [CI], 52.5%-70.7%). In 94 patients whose BBSs resolved at the end of FCSEMS indwell, the probability of remaining stent-free 5 years later was 77.4% (95% CI, 68.4%-86.4%). Serious stent-related adverse events occurred in 27 of 118 patients (22.9%); all resolved with medical therapy or repeated endoscopy. Multivariate analysis identified severe CP (hazard ratio, 2.4; 95% CI, 1.0-5.6; P = .046) and longer stricture length (hazard ratio, 1.2; 95% CI, 1.0-1.4; P = .022) as predictors of stricture recurrence. Conclusion: In patients with symptomatic BBSs secondary to CP, 5 years after placement of a single FCSEMS intended for 10 to 12 months indwell, more than 60% remained asymptomatic and stent-free with an acceptable safety profile. Temporary placement of a single FCSEMS may be considered as first-line treatment for patients with CP and BBSs. (Clinical trial registration number: NCT 01014390.)<br />info:eu-repo/semantics/published

Details

ISSN :
01014390 and 00165107
Database :
OpenAIRE
Journal :
Gastrointestinal Endoscopy, 91, 2, pp. 361-369.e3, Gastrointestinal Endoscopy, 91, 361-369.e3, Gastrointestinal Endoscopy, 91(2), 361-+. Mosby Inc., Gastrointestinal endoscopy, 91 (2
Accession number :
edsair.doi.dedup.....1c4dfee1b206f16218d831d9312b4419